No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d3so1C_, 1.0000, 0.00, 1.000, 87, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
2, d3so1F_, 0.9983, 0.14, 1.000, 87, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
3, d3i9hC_, 0.9983, 0.14, 0.977, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
4, d3so1A_, 0.9977, 0.16, 1.000, 87, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
5, d3so1G_, 0.9974, 0.17, 1.000, 88, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
6, d3so1B_, 0.9974, 0.17, 1.000, 87, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
7, d3i9hF_, 0.9972, 0.18, 0.977, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
8, d3so1H_, 0.9967, 0.19, 1.000, 89, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
9, d3snyA_, 0.9964, 0.19, 1.000, 89, 87, CRYSTAL STRUCTURE OF A MUTANT T82R OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
10, d3i9hG_, 0.9964, 0.20, 0.977, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
11, d3so1D_, 0.9963, 0.20, 0.977, 87, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
12, d3i9hB_, 0.9963, 0.20, 1.000, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
13, d3i9hE_, 0.9958, 0.20, 0.977, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
14, d3i9hA_, 0.9958, 0.22, 0.977, 88, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
15, d3i9hD_, 0.9957, 0.22, 0.977, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
16, d3iajA_, 0.9952, 0.22, 0.977, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII-IN ALTERNATE SPACE GROUP I422
17, d3snzA_, 0.9951, 0.23, 0.977, 87, 87, CRYSTAL STRUCTURE OF A MUTANT W39D OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
18, d3so1E_, 0.9947, 0.24, 0.966, 87, 87, CRYSTAL STRUCTURE OF A DOUBLE MUTANT T41S T82S OF A BETAGAMMA- CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
19, d3i9hH_, 0.9945, 0.25, 1.000, 88, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
20, d3so0F_, 0.9836, 0.25, 0.977, 87, 87, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
21, d5ht8A_, 0.9828, 0.50, 0.989, 87, 87, CRYSTAL STRUCTURE OF CLOSTRILLIN DOUBLE MUTANT (S17HS19H) IN COMPLEX WITH NICKEL
22, d3so0B_, 0.9820, 0.26, 0.953, 87, 86, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
23, d3so0G_, 0.9798, 0.27, 0.988, 87, 86, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
24, d3so0E_, 0.9777, 0.50, 0.989, 87, 87, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
25, d3so0A_, 0.9730, 0.36, 0.988, 86, 86, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
26, d3so0D_, 0.9661, 0.44, 0.977, 86, 86, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
27, d3so0C_, 0.9600, 0.37, 0.976, 85, 85, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
28, d1npsA_, 0.9490, 0.26, 0.988, 84, 84, CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF PROTEIN S
29, d3hzbD_, 0.9452, 0.75, 0.337, 88, 86, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
30, d3hzbE_, 0.9451, 0.93, 0.356, 90, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
31, d3hzbF_, 0.9431, 0.93, 0.356, 90, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
32, d3hzbC_, 0.9430, 0.93, 0.356, 90, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
33, d3hzbH_, 0.9423, 0.94, 0.356, 88, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
34, d3hzbB_, 0.9406, 0.94, 0.356, 88, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
35, d3hzbG_, 0.9403, 0.95, 0.356, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
36, d3hzbA_, 0.9355, 0.97, 0.356, 87, 87, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM FLAVOBACTERIUM JOHNSONIAE
37, d1prrA1, 0.8595, 0.97, 0.356, 87, 87, NMR-DERIVED THREE-DIMENSIONAL SOLUTION STRUCTURE OF PROTEIN S COMPLEXED WITH CALCIUM
38, p4psrA3, 0.8488, 0.90, 0.360, 86, 86, CRYSTAL STRUCTURE OF ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM IN COMPLEX WITH L-FUCOSE
39, p4ni3A3, 0.8460, 1.38, 0.337, 90, 86, CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE CLOSED FORM
40, d1prsA1, 0.8449, 1.38, 0.337, 90, 86, NMR-DERIVED THREE-DIMENSIONAL SOLUTION STRUCTURE OF PROTEIN S COMPLEXED WITH CALCIUM
41, p4pspA3, 0.8426, 1.30, 0.181, 86, 83, CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM
42, p4psrB3, 0.8376, 1.42, 0.167, 87, 84, CRYSTAL STRUCTURE OF ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM IN COMPLEX WITH L-FUCOSE
43, p4pspB3, 0.8367, 1.42, 0.167, 87, 84, CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE OPEN FORM
44, p4ni3B3, 0.8367, 1.48, 0.337, 90, 86, CRYSTAL STRUCTURE OF GH29 FAMILY ALPHA-L-FUCOSIDASE FROM FUSARIUM GRAMINEARUM IN THE CLOSED FORM
45, d1hdfA_, 0.8341, 1.45, 0.167, 86, 84, EVOLUTION OF THE EYE LENS BETA-GAMMA-CRYSTALLIN DOMAIN FOLD
46, d1hdfB_, 0.8340, 1.51, 0.167, 86, 84, EVOLUTION OF THE EYE LENS BETA-GAMMA-CRYSTALLIN DOMAIN FOLD
47, d2kp5A_, 0.8206, 1.51, 0.167, 86, 84, NMR STRUCTURE OF HAHELLIN A BETA-GAMMA CRYSTALLIN
48, p3enuA_, 0.8091, 1.52, 0.167, 86, 84, CRYSTAL STRUCTURE OF NITROLLIN A BETAGAMMA-CRYSTALLIN FROM NITROSOSPIRA MULTIFORMIS
49, p3entA_, 0.8066, 1.54, 0.253, 99, 83, CRYSTAL STRUCTURE OF NITROLLIN A BETAGAMMA-CRYSTALLIN FROM NITROSOSPIRA MULTIFORMIS-IN ALTERNATE SPACE GROUP (P65)
50, p3entB_, 0.8012, 1.55, 0.253, 99, 83, CRYSTAL STRUCTURE OF NITROLLIN A BETAGAMMA-CRYSTALLIN FROM NITROSOSPIRA MULTIFORMIS-IN ALTERNATE SPACE GROUP (P65)
51, d1prsA2, 0.7993, 1.68, 0.376, 91, 85, NMR-DERIVED THREE-DIMENSIONAL SOLUTION STRUCTURE OF PROTEIN S COMPLEXED WITH CALCIUM
52, d3so0H_, 0.7963, 1.68, 0.376, 91, 85, CRYSTAL STRUCTURE OF A MUTANT T41S OF A BETAGAMMA-CRYSTALLIN DOMAIN FROM CLOSTRIDIUM BEIJERINCKII
53, d1prrA2, 0.7954, 1.92, 0.165, 114, 85, NMR-DERIVED THREE-DIMENSIONAL SOLUTION STRUCTURE OF PROTEIN S COMPLEXED WITH CALCIUM
54, d1okiB2, 0.7899, 1.92, 0.176, 117, 85, CRYSTAL STRUCTURE OF TRUNCATED HUMAN BETA-B1-CRYSTALLIN
55, d3qk3A_, 0.7895, 1.92, 0.176, 117, 85, CRYSTAL STRUCTURE OF HUMAN BETA-CRYSTALLIN B3
56, d1okiA2, 0.7895, 1.94, 0.165, 117, 85, CRYSTAL STRUCTURE OF TRUNCATED HUMAN BETA-B1-CRYSTALLIN
57, d3qk3C_, 0.7874, 1.77, 0.325, 83, 83, CRYSTAL STRUCTURE OF HUMAN BETA-CRYSTALLIN B3
58, d2bv2A_, 0.7869, 0.69, 0.986, 72, 72, BETA GAMMA CRYSTALLIN FROM CIONA INTESTINALIS
59, d3qk3B_, 0.7866, 1.81, 0.325, 83, 83, CRYSTAL STRUCTURE OF HUMAN BETA-CRYSTALLIN B3
60, d2bv2B_, 0.7856, 2.15, 0.181, 92, 83, BETA GAMMA CRYSTALLIN FROM CIONA INTESTINALIS
61, d1bd7B_, 0.7844, 2.19, 0.133, 175, 83, CIRCULARLY PERMUTED BB2-CRYSTALLIN
62, d1bd7A_, 0.7842, 2.15, 0.181, 92, 83, CIRCULARLY PERMUTED BB2-CRYSTALLIN
63, d3lwkA1, 0.7827, 1.97, 0.134, 176, 82, CRYSTAL STRUCTURE OF HUMAN BETA-CRYSTALLIN A4 (CRYBA4)
64, d4jgfA_, 0.7817, 1.80, 0.312, 83, 80, CRYSTAL STRUCTURE OF THE CATARACT-CAUSING P23T GAMMA D-CRYSTALLIN MUTANT
65, d2kfbA2, 0.7815, 1.80, 0.312, 83, 80, THE STRUCTURE OF THE CATARACT CAUSING P23T MUTANT OF HUMAN GAMMA-D CRYSTALLIN
66, d2bb2A2, 0.7772, 1.98, 0.134, 176, 82, X-RAY ANALYSIS OF BETA B2-CRYSTALLIN AND EVOLUTION OF OLIGOMERIC LENS PROTEINS
67, d1dslA_, 0.7768, 1.98, 0.134, 176, 82, GAMMA B CRYSTALLIN C-TERMINAL DOMAIN
68, d1ha4A_, 0.7756, 1.78, 0.312, 83, 80, GAMMAS CRYSTALLIN C TERMINAL DOMAIN FROM HOMO SAPIENS
69, d4jgfB_, 0.7753, 2.14, 0.181, 171, 83, CRYSTAL STRUCTURE OF THE CATARACT-CAUSING P23T GAMMA D-CRYSTALLIN MUTANT
70, d1ytqA2, 0.7741, 2.13, 0.181, 176, 83, STRUCTURE OF NATIVE HUMAN BETA B2 CRYSTALLIN
71, d1hk0X2, 0.7738, 2.13, 0.181, 176, 83, HUMAN GAMMA-D CRYSTALLIN STRUCTURE AT 1.25 A RESOLUTION
72, d2nbrA_, 0.7734, 1.92, 0.160, 180, 81, THE SOLUTION STRUCTURE OF HUMAN GAMMAC-CRYSTALLIN
73, d1a7hB_, 0.7734, 1.92, 0.160, 180, 81, GAMMA S CRYSTALLIN C-TERMINAL DOMAIN
74, d1ha4B_, 0.7733, 2.01, 0.173, 171, 81, GAMMAS CRYSTALLIN C TERMINAL DOMAIN FROM HOMO SAPIENS
75, d3hz2B_, 0.7729, 2.09, 0.183, 88, 82, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN FROM AN ARCHAEA
76, d3hz2A_, 0.7725, 2.15, 0.205, 91, 83, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN FROM AN ARCHAEA
77, d3hz2D_, 0.7721, 2.20, 0.159, 88, 82, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN FROM AN ARCHAEA
78, d1h4aX2, 0.7716, 2.09, 0.134, 87, 82, HUMAN GAMMA-D CRYSTALLIN R58H MUTANT STRUCTURE AT 1.15 A RESOLUTION
79, d3hz2C_, 0.7715, 1.88, 0.175, 170, 80, CRYSTAL STRUCTURE OF A BETAGAMMA-CRYSTALLIN FROM AN ARCHAEA
80, d1a7hA_, 0.7715, 2.17, 0.181, 92, 83, GAMMA S CRYSTALLIN C-TERMINAL DOMAIN
81, d5ht9A_, 0.7714, 2.14, 0.173, 88, 81, CRYSTAL STRUCTURE OF M-CRYSTALLIN IN THE PRESENCE OF NICKEL
82, d4w9aA_, 0.7714, 2.14, 0.160, 173, 81, CRYSTAL STRUCTURE OF GAMMA-B CRYSTALLIN EXPRESSED IN E. COLI BASED ON MRNA VARIANT 2
83, d4gr7A_, 0.7712, 2.14, 0.160, 173, 81, THE HUMAN W42R GAMMA D-CRYSTALLIN MUTANT STRUCTURE AT 1.7A RESOLUTION
84, d1elpB2, 0.7706, 2.21, 0.134, 86, 82, GAMMA-D CRYSTALLIN STRUCTURE AT 1.95 A RESOLUTION
85, d1blbB2, 0.7704, 2.13, 0.134, 87, 82, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
86, d4w9bA_, 0.7703, 1.94, 0.291, 84, 79, CRYSTAL STRUCTURE OF GAMMA-B CRYSTALLIN EXPRESSED IN E. COLI BASED ON MRNA VARIANT 1
87, d4gr7X_, 0.7700, 1.94, 0.291, 84, 79, THE HUMAN W42R GAMMA D-CRYSTALLIN MUTANT STRUCTURE AT 1.7A RESOLUTION
88, d1elpA2, 0.7692, 1.95, 0.291, 84, 79, GAMMA-D CRYSTALLIN STRUCTURE AT 1.95 A RESOLUTION
89, d5ht9B_, 0.7687, 2.25, 0.183, 88, 82, CRYSTAL STRUCTURE OF M-CRYSTALLIN IN THE PRESENCE OF NICKEL
90, d4gcrA2, 0.7678, 1.95, 0.291, 84, 79, STRUCTURE OF THE BOVINE EYE LENS PROTEIN GAMMA-B (GAMMA-II)- CRYSTALLIN AT 1.47 ANGSTROMS
91, d2v2uA2, 0.7678, 2.20, 0.134, 86, 82, STRUCTURE OF MOUSE GAMMAC-CRYSTALLIN
92, d2g98B2, 0.7674, 1.95, 0.291, 84, 79, HUMAN GAMMA-D-CRYSTALLIN
93, d2v2uB2, 0.7672, 2.28, 0.159, 172, 82, STRUCTURE OF MOUSE GAMMAC-CRYSTALLIN
94, p2kljA2, 0.7671, 2.13, 0.173, 173, 81, SOLUTION STRUCTURE OF GAMMAD-CRYSTALLIN WITH RDC AND SAXS
95, d2jdfA2, 0.7669, 2.28, 0.195, 88, 82, HUMAN GAMMA-B CRYSTALLIN
96, d2g98A2, 0.7669, 2.19, 0.205, 91, 83, HUMAN GAMMA-D-CRYSTALLIN
97, d2m3cA2, 0.7658, 2.28, 0.159, 172, 82, SOLUTION STRUCTURE OF GAMMAM7-CRYSTALLIN
98, d5vh1A2, 0.7653, 2.14, 0.173, 173, 81, CRYSTAL STRUCTURE OF CHICKEN GAMMA S CRYSTALLIN
99, d1blbC2, 0.7652, 2.33, 0.183, 88, 82, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
100, d1i5iA2, 0.7639, 1.90, 0.291, 84, 79, THE C18S MUTANT OF BOVINE (GAMMA-B)-CRYSTALLIN
101, d2a5mA2, 0.7636, 2.19, 0.148, 89, 81, NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN FROM JOINT REFINEMENT WITH SAXS DATA
102, d1hk0X1, 0.7635, 2.21, 0.159, 88, 82, HUMAN GAMMA-D CRYSTALLIN STRUCTURE AT 1.25 A RESOLUTION
103, d1gamB_, 0.7631, 1.94, 0.175, 85, 80, GAMMA B CRYSTALLIN TRUNCATED C-TERMINAL DOMAIN
104, d1gamA_, 0.7619, 2.26, 0.159, 88, 82, GAMMA B CRYSTALLIN TRUNCATED C-TERMINAL DOMAIN
105, d1e7nA_, 0.7616, 2.02, 0.173, 93, 81, THE N-TERMINAL DOMAIN OF BETA-B2-CRYSTALLIN RESEMBLES THE PUTATIVE ANCESTRAL HOMODIMER
106, d1ammA2, 0.7615, 2.25, 0.159, 89, 82, 1.2 ANGSTROM STRUCTURE OF GAMMA-B CRYSTALLIN AT 150K
107, d2a5mA1, 0.7614, 2.11, 0.173, 86, 81, NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN FROM JOINT REFINEMENT WITH SAXS DATA
108, d1h4aX1, 0.7610, 2.15, 0.195, 88, 82, HUMAN GAMMA-D CRYSTALLIN R58H MUTANT STRUCTURE AT 1.15 A RESOLUTION
109, d1m8uA1, 0.7594, 2.15, 0.110, 87, 82, CRYSTAL STRUCTURE OF BOVINE GAMMA-E AT 1.65 ANG RESOLUTION
110, d1gcsA2, 0.7593, 2.24, 0.205, 91, 83, STRUCTURE OF THE BOVINE GAMMA-B CRYSTALLIN AT 150K
111, d1e7nB_, 0.7591, 2.31, 0.159, 88, 82, THE N-TERMINAL DOMAIN OF BETA-B2-CRYSTALLIN RESEMBLES THE PUTATIVE ANCESTRAL HOMODIMER
112, d1zwoA2, 0.7581, 2.08, 0.136, 87, 81, NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN
113, d2m3cA1, 0.7578, 1.96, 0.200, 85, 80, SOLUTION STRUCTURE OF GAMMAM7-CRYSTALLIN
114, d2g98A1, 0.7564, 2.30, 0.159, 86, 82, HUMAN GAMMA-D-CRYSTALLIN
115, d1blbA2, 0.7563, 2.15, 0.160, 86, 81, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
116, d1zieA1, 0.7558, 2.03, 0.200, 89, 80, HYDROGENATED GAMMAE CRYSTALLIN IN D2O SOLVENT
117, d1a5dA1, 0.7549, 2.31, 0.159, 89, 82, GAMMAE CRYSTALLIN FROM RAT LENS
118, d1zirA1, 0.7547, 1.96, 0.237, 90, 80, DEUTERATED GAMMAE CRYSTALLIN IN H2O SOLVENT
119, d2jdfA1, 0.7543, 2.02, 0.200, 85, 80, HUMAN GAMMA-B CRYSTALLIN
120, d1zwoA1, 0.7541, 2.07, 0.250, 85, 80, NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN
121, d1blbD2, 0.7541, 2.27, 0.159, 89, 82, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
122, d1a5dB1, 0.7535, 2.07, 0.200, 89, 80, GAMMAE CRYSTALLIN FROM RAT LENS
123, d1zgtA1, 0.7533, 2.25, 0.146, 87, 82, STRUCTURE OF HYDROGENATED RAT GAMMA E CRYSTALLIN IN H2O
124, d1ziqA1, 0.7532, 1.98, 0.250, 86, 80, DEUTERATED GAMMAE CRYSTALLIN IN D2O SOLVENT
125, d1zwmA1, 0.7529, 2.05, 0.200, 85, 80, NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN
126, d2v2uB1, 0.7504, 2.21, 0.193, 91, 83, STRUCTURE OF MOUSE GAMMAC-CRYSTALLIN
127, d1elpB1, 0.7498, 2.04, 0.250, 84, 80, GAMMA-D CRYSTALLIN STRUCTURE AT 1.95 A RESOLUTION
128, d2g98B1, 0.7497, 2.05, 0.250, 84, 80, HUMAN GAMMA-D-CRYSTALLIN
129, d1a5dA2, 0.7495, 2.05, 0.250, 84, 80, GAMMAE CRYSTALLIN FROM RAT LENS
130, d1elpA1, 0.7490, 2.05, 0.225, 85, 80, GAMMA-D CRYSTALLIN STRUCTURE AT 1.95 A RESOLUTION
131, d1i5iA1, 0.7487, 2.03, 0.237, 90, 80, THE C18S MUTANT OF BOVINE (GAMMA-B)-CRYSTALLIN
132, d1ytqA1, 0.7482, 2.27, 0.205, 91, 83, STRUCTURE OF NATIVE HUMAN BETA B2 CRYSTALLIN
133, d2kfbA1, 0.7481, 2.04, 0.250, 84, 80, THE STRUCTURE OF THE CATARACT CAUSING P23T MUTANT OF HUMAN GAMMA-D CRYSTALLIN
134, d1ammA1, 0.7481, 2.06, 0.250, 84, 80, 1.2 ANGSTROM STRUCTURE OF GAMMA-B CRYSTALLIN AT 150K
135, d2v2uA1, 0.7480, 2.06, 0.250, 84, 80, STRUCTURE OF MOUSE GAMMAC-CRYSTALLIN
136, d2jdgA1, 0.7476, 2.05, 0.237, 90, 80, AFFILIN BASED ON HUMAN GAMMA-B CRYSTALLIN
137, d2bb2A1, 0.7474, 2.08, 0.212, 85, 80, X-RAY ANALYSIS OF BETA B2-CRYSTALLIN AND EVOLUTION OF OLIGOMERIC LENS PROTEINS
138, d1ziqA2, 0.7472, 2.07, 0.237, 85, 80, DEUTERATED GAMMAE CRYSTALLIN IN D2O SOLVENT
139, d1zieA2, 0.7464, 2.06, 0.200, 85, 80, HYDROGENATED GAMMAE CRYSTALLIN IN D2O SOLVENT
140, d1gcsA1, 0.7462, 2.36, 0.148, 89, 81, STRUCTURE OF THE BOVINE GAMMA-B CRYSTALLIN AT 150K
141, d1zirA2, 0.7460, 2.09, 0.237, 85, 80, DEUTERATED GAMMAE CRYSTALLIN IN H2O SOLVENT
142, d4gcrA1, 0.7459, 2.07, 0.237, 85, 80, STRUCTURE OF THE BOVINE EYE LENS PROTEIN GAMMA-B (GAMMA-II)- CRYSTALLIN AT 1.47 ANGSTROMS
143, d1zgtA2, 0.7446, 2.21, 0.200, 89, 80, STRUCTURE OF HYDROGENATED RAT GAMMA E CRYSTALLIN IN H2O
144, d1a45A1, 0.7443, 2.08, 0.203, 85, 79, GAMMAF CRYSTALLIN FROM BOVINE LENS
145, d1blbD1, 0.7439, 2.07, 0.237, 85, 80, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
146, d1blbC1, 0.7437, 2.08, 0.212, 85, 80, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
147, d1blbB1, 0.7435, 2.15, 0.187, 86, 80, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
148, d2dadA1, 0.7431, 2.17, 0.200, 90, 80, SOLUTION STRUCTURE OF THE FIFTH CRYSTALL DOMAIN OF THE NON- LENS PROTEIN ABSENT IN MELANOMA 1
149, d1zwmA2, 0.7409, 2.33, 0.148, 89, 81, NMR STRUCTURE OF MURINE GAMMA-S CRYSTALLIN
150, d1a5dB2, 0.7373, 2.31, 0.148, 88, 81, GAMMAE CRYSTALLIN FROM RAT LENS
151, p2kljA1, 0.7356, 2.09, 0.237, 85, 80, SOLUTION STRUCTURE OF GAMMAD-CRYSTALLIN WITH RDC AND SAXS
152, d1a45A2, 0.7344, 2.36, 0.148, 89, 81, GAMMAF CRYSTALLIN FROM BOVINE LENS
153, d1blbA1, 0.7339, 2.08, 0.237, 85, 80, CLOSE PACKING OF AN OLIGOMERIC EYE LENS BETA-CRYSTALLIN INDUCES LOSS OF SYMMETRY AND ORDERING OF SEQUENCE EXTENSIONS
154, d5vh1A1, 0.7334, 2.36, 0.148, 89, 81, CRYSTAL STRUCTURE OF CHICKEN GAMMA S CRYSTALLIN
155, p1yhpA1, 0.7334, 2.10, 0.250, 84, 80, SOLUTION STRUCTURE OF CA2+-FREE DDCAD-1
156, d4fd9A_, 0.7317, 2.22, 0.210, 92, 81, CRYSTAL STRUCTURE OF THE THIRD BETA-GAMMA-CRYSTALLIN DOMAIN OF CRYBG3 (BETAGAMMA-CRYSTALLIN DOMAIN-CONTAINING PROTEIN 3) FROM MUS MUSCULUS
157, d4fd9B_, 0.7309, 2.32, 0.210, 96, 81, CRYSTAL STRUCTURE OF THE THIRD BETA-GAMMA-CRYSTALLIN DOMAIN OF CRYBG3 (BETAGAMMA-CRYSTALLIN DOMAIN-CONTAINING PROTEIN 3) FROM MUS MUSCULUS
158, d1m8uA2, 0.7289, 2.37, 0.225, 90, 80, CRYSTAL STRUCTURE OF BOVINE GAMMA-E AT 1.65 ANG RESOLUTION
159, p5ht7C_, 0.7279, 1.81, 0.184, 80, 76, CRYSTAL STRUCTURE OF A TRANSITION-METAL-ION-BINDING BETAGAMMA- CRYSTALLIN FROM METHANOSAETA THERMOPHILA
160, d1okiA1, 0.7265, 1.81, 0.184, 80, 76, CRYSTAL STRUCTURE OF TRUNCATED HUMAN BETA-B1-CRYSTALLIN
161, d1okiB1, 0.7264, 2.20, 0.136, 87, 81, CRYSTAL STRUCTURE OF TRUNCATED HUMAN BETA-B1-CRYSTALLIN
162, p5ht7B_, 0.7256, 2.22, 0.150, 89, 80, CRYSTAL STRUCTURE OF A TRANSITION-METAL-ION-BINDING BETAGAMMA- CRYSTALLIN FROM METHANOSAETA THERMOPHILA
163, p5ht7A_, 0.7256, 1.99, 0.197, 81, 76, CRYSTAL STRUCTURE OF A TRANSITION-METAL-ION-BINDING BETAGAMMA- CRYSTALLIN FROM METHANOSAETA THERMOPHILA
164, p4akaA_, 0.7256, 2.45, 0.160, 89, 81, IPSE ALPHA-1 AN IGE-BINDING CRYSTALLIN
165, p4el6A_, 0.7210, 2.06, 0.212, 94, 80, CRYSTAL STRUCTURE OF IPSE/ALPHA-1 FROM SCHISTOSOMA MANSONI EGGS
166, p2b1oA1, 0.7210, 2.17, 0.275, 90, 80, SOLUTION STRUCTURE OF CA2+-BOUND DDCAD-1
167, d2m3uA2, 0.7101, 2.11, 0.192, 94, 78, SOLUTION-STATE NMR STRUCTURE OF CATARACT-RELATED HUMAN GAMMA(S)- CRYSTALLIN POINT VARIANT G18V
168, d2m3tA2, 0.7091, 2.11, 0.192, 94, 78, SOLUTION-STATE NMR STRUCTURE OF WILD-TYPE HUMAN GAMMA(S)-CRYSTALLIN
169, d1ag4A_, 0.7073, 2.57, 0.155, 92, 84, NMR STRUCTURE OF SPHERULIN 3A (S3A) FROM PHYSARUM POLYCEPHALUM MINIMIZED AVERAGE STRUCTURE
170, d4iauA_, 0.7071, 2.57, 0.155, 92, 84, ATOMIC RESOLUTION STRUCTURE OF GEODIN A BETA-GAMMA CRYSTALLIN FROM GEODIA CYDONIUM
171, d2m3uA1, 0.7071, 2.54, 0.155, 92, 84, SOLUTION-STATE NMR STRUCTURE OF CATARACT-RELATED HUMAN GAMMA(S)- CRYSTALLIN POINT VARIANT G18V
172, d2m3tA1, 0.7051, 2.45, 0.160, 88, 81, SOLUTION-STATE NMR STRUCTURE OF WILD-TYPE HUMAN GAMMA(S)-CRYSTALLIN
173, p3ujzA4, 0.6876, 2.19, 0.152, 82, 79, CRYSTAL STRUCTURE OF ENTEROHEMORRHAGIC E. COLI STCE
174, p3cw3A_, 0.6482, 2.13, 0.152, 90, 79, CRYSTAL STRUCTURE OF AIM1G1
175, p5a98A_, 0.6116, 2.13, 0.152, 90, 79, CRYSTAL STRUCTURE OF TRICHOPLUSIA NI CPV15 POLYHEDRA
176, d1wktA_, 0.5933, 2.22, 0.152, 82, 79, WILLIOPSIS MRAKII KILLER TOXIN NMR SOLUTION STRUCTURE
177, p5a96A_, 0.5842, 2.24, 0.165, 82, 79, CRYSTAL STRUCTURE OF LYMANTRIA DISPAR CPV14 POLYHEDRA
178, p5a8uA_, 0.5803, 2.24, 0.165, 82, 79, CRYSTAL STRUCTURE OF ORGYIA PSEUDOTSUGATA CPV5 POLYHEDRA
179, p5a8tA_, 0.5789, 2.00, 0.177, 106, 79, CRYSTAL STRUCTURE OF ANTHERAEA MYLITTA CPV4 POLYHEDRA TYPE 2
180, p5a99A_, 0.5785, 2.00, 0.177, 106, 79, CRYSTAL STRUCTURE OF OPEROPHTERA BRUMATA CPV19 POLYHEDRA
181, d1gh5A_, 0.5783, 2.14, 0.175, 97, 80, ANTIFUNGAL PROTEIN FROM STREPTOMYCES TENDAE TU901 NMR AVERAGE STRUCTURE
182, d1g6eA_, 0.5767, 2.07, 0.208, 93, 77, ANTIFUNGAL PROTEIN FROM STREPTOMYCES TENDAE TU901 30- CONFORMERS ENSEMBLE
183, d2k1wA1, 0.5725, 2.21, 0.127, 87, 79, NMR SOLUTION STRUCTURE OF M-CRYSTALLIN IN CALCIUM LOADED FORM(HOLO).
184, d1c01A_, 0.5725, 2.48, 0.125, 87, 80, SOLUTION STRUCTURE OF MIAMP1 A PLANT ANTIMICROBIAL PROTEIN
185, p5a8sA_, 0.5707, 2.41, 0.202, 103, 84, CRYSTAL STRUCTURE OF ANTHERAEA MYLITTA CPV4 POLYHEDRA TYPE 1
186, d1f53A_, 0.5694, 2.41, 0.202, 103, 84, NMR STRUCTURE OF KILLER TOXIN-LIKE PROTEIN SKLP
187, p4zqxA_, 0.5673, 2.04, 0.213, 158, 75, A REVISED PARTIALITY MODEL AND POST-REFINEMENT ALGORITHM FOR X-RAY FREE-ELECTRON LASER DATA
188, p4s1kA_, 0.5672, 2.04, 0.213, 158, 75, STRUCTURE OF URANOTAENIA SAPPHIRINA CYPOVIRUS (CPV17) POLYHEDRIN AT 100 K
189, p4s1lA_, 0.5666, 2.18, 0.241, 90, 79, STRUCTURE OF URANOTAENIA SAPPHIRINA CYPOVIRUS (CPV17) POLYHEDRIN AT 298 K
190, p3rj2X_, 0.5647, 2.20, 0.266, 90, 79, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A NOVEL HISTONE H3 BINDING PROTEIN ORF158L FROM THE SINGAPORE GROUPER IRIDOVIRUS (SGIV)
191, p5a8vA_, 0.5580, 2.27, 0.114, 98, 79, CRYSTAL STRUCTURE OF ORGYIA PSEUDOTSUGATA CPV5 POLYHEDRA WITH SEMET SUBSTITUTION
192, p5a9cA_, 0.5567, 2.27, 0.114, 98, 79, CRYSTAL STRUCTURE OF ANTHERAEA MYLITTA CPV4 POLYHEDRA BASE DOMAIN DELETED MUTANT
193, d2k1xA1, 0.5566, 2.69, 0.133, 93, 75, NMR SOLUTION STRUCTURE OF M-CRYSTALLIN IN CALCIUM FREE FORM (APO).
194, p5a9aA_, 0.5532, 2.69, 0.133, 93, 75, CRYSTAL STRUCTURE OF SIMULIUM UBIQUITUM CPV20 POLYHEDRA
195, p5yrbA_, 0.5475, 3.08, 0.050, 219, 80, CRYSTAL STRUCTURE OF OXIDIZED CYPOVIRUS POLYHEDRA R13A/E73C/Y83C/S193C/A194C MUTANT
196, p5a9pA_, 0.5473, 3.08, 0.050, 219, 80, CRYSTAL STRUCTURE OF OPEROPHTERA BRUMATA CPV18 POLYHEDRA
197, p5fy5A1, 0.5421, 2.66, 0.067, 88, 75, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH FUMARATE
198, p5fzdA1, 0.5404, 2.77, 0.040, 88, 75, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH L-2-HYDROXYGLUTARATE
199, p5yr9A_, 0.5402, 3.07, 0.079, 236, 76, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA R13A/E73C/Y83C MUTANT
200, p4otsA_, 0.5401, 3.07, 0.079, 236, 76, CRYSTAL STRUCTURE OF ISOLATED OPEROPHTERA BRUMATA CPV18
201, p2oh5A_, 0.5399, 3.33, 0.085, 234, 82, THE CRYSTAL STRUCTURE OF INFECTIOUS CYPOVIRUS POLYHEDRA
202, p5fzeA1, 0.5397, 3.33, 0.085, 234, 82, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MC3960
203, p4x35A_, 0.5395, 3.22, 0.092, 203, 76, A MICRO-PATTERNED SILICON CHIP AS SAMPLE HOLDER FOR MACROMOLECULAR CRYSTALLOGRAPHY EXPERIMENTS WITH MINIMAL BACKGROUND SCATTERING
204, p6eiyA1, 0.5394, 3.44, 0.098, 230, 82, CRYSTAL STRUCTURE OF KDM5B IN COMPLEX WITH KDOPZ000034A. 
205, p5fv3A1, 0.5393, 3.44, 0.098, 230, 82, CRYSTAL STRUCTURE OF HUMAN JARID1B CONSTRUCT C2 IN COMPLEX WITH N-OXALYLGLYCINE.
206, p4otvA_, 0.5390, 2.35, 0.119, 87, 67, CRYSTAL STRUCTURE OF IN CELLULO OPEROPHTERA BRUMATA CPV18
207, p5fyuA1, 0.5388, 2.37, 0.119, 87, 67, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT 3-AMINO-4-METHYL-13-DIHYDRO-2H-INDOL-2-ONE (N10042A)
208, p5lw9A1, 0.5386, 2.37, 0.119, 87, 67, CRYSTAL STRUCTURE OF HUMAN JARID1B IN COMPLEX WITH S40563A
209, p5fzlA1, 0.5384, 2.99, 0.128, 84, 78, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT 3-METHYL-N-PYRIDIN-4-YL-12- OXAZOLE-5-CARBOXAMIDE (N09954A) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
210, p5fyyA1, 0.5375, 2.99, 0.128, 84, 78, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MAYBRIDGE FRAGMENT 3-PYRIDIN-3-YLANILINE (N05798A) (LIGAND MODELLED BASED ON PANDDA EVENT MAP)
211, p5yr1A_, 0.5371, 2.77, 0.096, 76, 73, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA R13A/E73C/Y83C/S193C/A194C MUTANT
212, p2oh6A2, 0.5369, 2.77, 0.096, 76, 73, THE CRYSTAL STRUCTURE OF RECOMBINANT CYPOVIRUS POLYHEDRA
213, p5lwbA1, 0.5367, 3.76, 0.075, 235, 80, CRYSTAL STRUCTURE OF HUMAN JARID1B IN COMPLEX WITH S40650A
214, p5mqwA_, 0.5366, 3.76, 0.075, 235, 80, HIGH-SPEED FIXED-TARGET SERIAL VIRUS CRYSTALLOGRAPHY
215, p5fplA1, 0.5360, 2.80, 0.116, 84, 69, CRYSTAL STRUCTURE OF HUMAN JARID1B IN COMPLEX WITH CCT363901
216, p5gqkA2, 0.5350, 2.80, 0.116, 84, 69, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA MUTANT WITH DELETION OF GLY192-ALA194
217, p5a1fA1, 0.5350, 3.19, 0.117, 206, 77, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PLU1 IN COMPLEX WITH N-OXALYLGLYCINE.
218, p6eiuA1, 0.5346, 3.16, 0.117, 206, 77, CRYSTAL STRUCTURE OF KDM5B IN COMPLEX WITH KDOPZ29A 
219, p5yrcA2, 0.5346, 3.16, 0.117, 206, 77, CRYSTAL STRUCTURE OF OXIDIZED CYPOVIRUS POLYHEDRA R13A/E73C/Y83C MUTANT
220, p6ej0A1, 0.5345, 3.20, 0.117, 206, 77, CRYSTAL STRUCTURE OF KDM5B IN COMPLEX WITH KDOPZ000049A. 
221, p6ej1A1, 0.5339, 3.21, 0.080, 133, 75, CRYSTAL STRUCTURE OF KDM5B IN COMPLEX WITH KDOPZ48A. 
222, p5gqjA2, 0.5339, 3.21, 0.080, 133, 75, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA MUTANT WITH DELETION OF SER193 AND ALA194
223, p5axvA2, 0.5339, 3.80, 0.099, 227, 81, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA R13K MUTANT
224, p2oh7A_, 0.5336, 3.36, 0.026, 203, 76, THE CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA CONTAINING THE HUMAN ZIP-KINASE
225, p5gqlA2, 0.5333, 3.48, 0.286, 84, 77, CRYSTAL STRUCTURE OF WILD TYPE CYPOVIRUS POLYHEDRA
226, p5gqnA2, 0.5330, 3.34, 0.091, 225, 77, CRYSTAL STRUCTURE OF IN CELLULO CYPOVIRUS POLYHEDRA MUTANT WITH DELETION OF GLY192-ALA194
227, p5iveA_, 0.5327, 3.34, 0.091, 225, 77, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N8 ( 5-METHYL-7-OXO-6- (PROPAN-2-YL)-47-DIHYDROPYRAZOLO[15-A]PYRIMIDINE-3-CARBONITRILE)
228, p6bh3A_, 0.5324, 3.74, 0.090, 236, 78, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-N-(1-(3-ISOPROPYL- 1H-PYRAZOLE-5-CARBONYL)PYRROLIDIN-3-YL)CYCLOPROPANECARBOXAMIDE (COMPOUND N55)
229, p5fwjA1, 0.5321, 3.75, 0.077, 232, 78, CRYSTAL STRUCTURE OF HUMAN JARID1C IN COMPLEX WITH KDM5-C49
230, p5a3tA1, 0.5315, 3.41, 0.041, 307, 73, CRYSTAL STRUCTURE OF HUMAN PLU-1 (JARID1B) IN COMPLEX WITH KDM5-C49 (2-(((2-((2-(DIMETHYLAMINO)ETHYL)(ETHYL)AMINO)-2- OXOETHYL)AMINO)METHYL) ISONICOTINIC ACID).
231, p6bh1A_, 0.5314, 3.43, 0.041, 331, 73, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (S)-2-((2- CHLOROPHENYL)(2-(PIPERIDIN-1-YL)ETHOXY)METHYL)-1L2-PYRROLO[32- B]PYRIDINE-7-CARBOXYLIC ACID (COMPOUND N52)
232, p6bh2A_, 0.5308, 3.42, 0.052, 236, 77, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR (R)-N-(1-(3-ISOPROPYL- 1H-PYRAZOLE-5-CARBONYL)PYRROLIDIN-3-YL)CYCLOPROPANECARBOXAMIDE (COMPOUND N54)
233, p5fybA1, 0.5306, 3.89, 0.100, 232, 80, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MC1648
234, p5fzaA1, 0.5304, 3.38, 0.053, 232, 76, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT 2-PIPERIDIN-4-YLOXY-5-(TRIFLUOROMETHYL)PYRIDINE (N10072A) (LIGAND MODELLED BASED ON PANDDA EVENT MAP)
235, p5iwfA_, 0.5300, 3.44, 0.041, 310, 73, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-(((2-((2- (DIMETHYLAMINO)ETHYL)(ETHYL)AMINO)-2-OXOETHYL)AMINO)METHYL) ISONICOTINAMID
236, p5iw0A_, 0.5300, 3.83, 0.077, 230, 78, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N19 [2-(5-((4-CHLORO-2- METHYLBENZYL)OXY)-1H-PYRAZOL-1-YL)ISONICOTINIC ACID]
237, p5fz4A1, 0.5299, 3.43, 0.041, 309, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT (3R)-1-[(3-PHENYL-124-OXADIAZOL-5-YL)METHYL]PYRROLIDIN-3-OL (N10057A) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
238, p5ivyA_, 0.5298, 3.45, 0.041, 334, 73, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N16 [3-(2-(4- CHLOROPHENYL)ACETAMIDO)ISONICOTINIC ACID]
239, p6bgyA_, 0.5297, 3.90, 0.100, 232, 80, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR 2-((2-CHLOROPHENYL)(2- (1-METHYLPYRROLIDIN-2-YL)ETHOXY)METHYL)-1H-PYRROLO[32-B]PYRIDINE-7- CARBOXYLIC ACID(COMPOUND 46)
240, p5ivjA_, 0.5297, 3.44, 0.041, 310, 73, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N11 [3-({1-[2-(44- DIFLUOROPIPERIDIN-1-YL)ETHYL]-5-FLUORO-1H-INDAZOL-3-YL}AMINO) PYRIDINE-4-CARBOXYLIC ACID]
241, p5fzgA1, 0.5297, 3.42, 0.041, 309, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MC3948
242, p5fysA1, 0.5297, 3.44, 0.041, 306, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH D-2-HYDROXYGLUTARATE
243, p5funA1, 0.5297, 3.45, 0.041, 308, 73, CRYSTAL STRUCTURE OF HUMAN JARID1B IN COMPLEX WITH GSK467
244, p5fpuA1, 0.5293, 3.75, 0.101, 238, 79, CRYSTAL STRUCTURE OF HUMAN JARID1B IN COMPLEX WITH GSKJ1
245, p5islA_, 0.5288, 3.75, 0.101, 238, 79, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR C49 (2-{[(2-{[(E)-2- (DIMETHYLAMINO)ETHENYL](ETHYL)AMINO}-2-OXOETHYL) AMINO]METHYL}PYRIDINE-4-CARBOXYLIC ACID)
246, p5fzmA1, 0.5288, 3.78, 0.078, 197, 77, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT 5-(2-FLUOROPHENYL)-13-OXAZOLE-4-CARBOXYLIC ACID (N09989B) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
247, p5fzkA1, 0.5288, 3.45, 0.041, 331, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT N3-DIMETHYL-N-(PYRIDIN-3- YLMETHYL)-12-OXAZOLE-5-CARBOXAMIDE (N10051A) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
248, p5fz6A1, 0.5288, 3.75, 0.051, 232, 79, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MAYBRIDGE FRAGMENT N05859B (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
249, p5fytA1, 0.5288, 3.44, 0.041, 334, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT (5-FLUORO-2-OXO-23-DIHYDRO-1H-INDOL-3-YL)ACETIC ACID (N09996A)
250, p6ek6A1, 0.5287, 3.65, 0.064, 194, 78, CRYSTAL STRUCTURE OF KDM5B IN COMPLEX WITH S49195A.
251, p5fupA1, 0.5285, 3.43, 0.055, 329, 73, CRYSTAL STRUCTURE OF HUMAN JARID1B IN COMPLEX WITH 2-OXOGLUTARATE.
252, p5a3wA1, 0.5284, 3.50, 0.041, 332, 73, CRYSTAL STRUCTURE OF HUMAN PLU-1 (JARID1B) IN COMPLEX WITH PYRIDINE-26-DICARBOXYLIC ACID (PDCA)
253, p5fyvA1, 0.5283, 3.68, 0.066, 197, 76, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH OXALOACETATE
254, p5a3pA1, 0.5283, 3.43, 0.055, 306, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PLU1 (JARID1B).
255, p5fz8A1, 0.5282, 3.50, 0.041, 306, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MALATE
256, p5fyzA1, 0.5281, 3.67, 0.079, 194, 76, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 3D FRAGMENT 2-(2-OXO-23-DIHYDRO-1H-INDOL-3-YL)ACETONITRILE (N10063A)
257, p5ivvA_, 0.5277, 3.68, 0.079, 197, 76, LINKED KDM5A JMJ DOMAIN BOUND TO THE INHIBITOR N12 [3-((1-METHYL-1H- PYRROLO[23-B]PYRIDIN-3-YL)AMINO)ISONICOTINIC ACID]
258, p5fz7A1, 0.5276, 3.75, 0.078, 232, 77, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MAYBRIDGE FRAGMENT ETHYL 2-AMINO-4- THIOPHEN-2-YLTHIOPHENE-3-CARBOXYLATE (N06131B) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
259, p5exyA2, 0.5274, 3.68, 0.079, 197, 76, CRYSTAL STRUCTURE OF IN CELLULO RECOMBINANT CPV1 POLYHEDRA
260, p5yhbA_, 0.5273, 3.70, 0.079, 194, 76, CRYSTAL STRUCTURE OF PD(ALLYL)/POLYHEDRA MUTANT WITH DELETION OF GLY192-ALA194
261, p5fz0A1, 0.5273, 3.59, 0.055, 305, 73, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH 25-DICHLORO-N-(PYRIDIN-3-YL)THIOPHENE-3-CARBOXAMIDE (N08137B) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
262, p5fzbA1, 0.5270, 3.42, 0.042, 302, 72, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MAYBRIDGE FRAGMENT 4-PYRIDYLTHIOUREA (N06275B) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
263, p5exzA2, 0.5269, 3.44, 0.055, 313, 73, CRYSTAL STRUCTURE OF PURIFIED RECOMBINANT CPV1 POLYHEDRA
264, p3al5B_, 0.5267, 3.79, 0.053, 380, 75, CRYSTAL STRUCTURE OF HUMAN TYW5
265, p5yrdA1, 0.5265, 3.62, 0.054, 297, 74, CRYSTAL STRUCTURE OF OXIDIZED CYPOVIRUS POLYHEDRA R13A/S193C/A194C MUTANT
266, p5yraA1, 0.5265, 3.77, 0.053, 295, 75, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA R13A/S193C/A194C MUTANT
267, p5fzcA1, 0.5262, 3.64, 0.054, 309, 74, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MAYBRIDGE FRAGMENT 45-DIHYDRONAPHTHO(12- B)THIOPHENE-2-CARBOXYLICACID (N11181A) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
268, p5gqmA2, 0.5261, 3.54, 0.041, 307, 73, CRYSTAL STRUCTURE OF IN CELLULO WILD TYPE CYPOVIRUS POLYHEDRA
269, p5axuA2, 0.5261, 3.65, 0.054, 298, 74, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA R13A MUTANT
270, p5gqiA2, 0.5258, 3.61, 0.054, 306, 74, CRYSTAL STRUCTURE OF CYPOVIRUS POLYHEDRA MUTANT WITH DELETION OF ALA194
271, p5mm2C_, 0.5251, 3.62, 0.054, 331, 74, NORA VIRUS STRUCTURE
272, p5fz9A1, 0.5247, 3.63, 0.054, 300, 74, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH MAYBRIDGE FRAGMENT THIENO(32-B)THIOPHENE- 5-CARBOXYLIC ACID (N06263B) (LIGAND MODELLED BASED ON PANDDA EVENT MAP SGC - DIAMOND I04-1 FRAGMENT SCREENING)
273, p6einA1, 0.5242, 3.64, 0.054, 297, 74, CRYSTAL STRUCTURE OF KDM5B IN COMPLEX WITH S49365A. 
274, p5nfnD_, 0.5241, 3.63, 0.054, 296, 74, JMJD7 IN COMPLEX WITH MN AND 2OG IN THE H32 FORM
275, p3wvzA1, 0.5233, 3.64, 0.054, 309, 74, CRYSTAL STRUCTURE OF HIKESHI A NEW NUCLEAR TRANSPORT RECEPTOR OF HSP70
276, p5yhaA2, 0.5232, 3.65, 0.054, 332, 74, CRYSTAL STRUCTURE OF PD(ALLYL)/WILD TYPE POLYHEDRA
277, p2y0oA_, 0.5227, 3.65, 0.054, 309, 74, THE STRUCTURE OF A D-LYXOSE ISOMERASE FROM THE SIGMAB REGULON OF BACILLUS SUBTILIS
278, p3ww0A1, 0.5214, 3.63, 0.054, 309, 74, CRYSTAL STRUCTURE OF F97A MUTANT A NEW NUCLEAR TRANSPORT RECEPTOR OF HSP70
279, p5jwpA_, 0.5212, 3.62, 0.054, 306, 74, CRYSTAL STRUCTURE OF HUMAN FIH D201E VARIANT IN COMPLEX WITH ZN ALPHA-KETOGLUTARATE AND HIF1 ALPHA PEPTIDE.
280, p5fz1A1, 0.5209, 3.63, 0.054, 309, 74, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX 24-DICHLORO-N-PYRIDIN-3-YLBENZAMIDE (E48115B) (LIGAND MODELLED BASED PANDDA EVENT MAP)
281, p3ww0B1, 0.5209, 3.64, 0.054, 308, 74, CRYSTAL STRUCTURE OF F97A MUTANT A NEW NUCLEAR TRANSPORT RECEPTOR OF HSP70
282, p4aapB_, 0.5204, 3.44, 0.042, 306, 71, CRYSTAL STRUCTURE OF JMJD5 DOMAIN OF HUMAN LYSINE-SPECIFIC DEMETHYLASE 8 (KDM8) IN COMPLEX WITH N-OXALYLGLYCINE (NOG)
283, p3puqA2, 0.5200, 3.63, 0.054, 309, 74, CEKDM7A FROM C.ELEGANS COMPLEX WITH ALPHA-KG
284, p4aapA_, 0.5196, 3.47, 0.055, 304, 73, CRYSTAL STRUCTURE OF JMJD5 DOMAIN OF HUMAN LYSINE-SPECIFIC DEMETHYLASE 8 (KDM8) IN COMPLEX WITH N-OXALYLGLYCINE (NOG)
285, d1h2lA_, 0.5196, 3.65, 0.054, 332, 74, FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE
286, p3puqC2, 0.5192, 3.70, 0.054, 334, 74, CEKDM7A FROM C.ELEGANS COMPLEX WITH ALPHA-KG
287, p5nfnB_, 0.5191, 3.66, 0.054, 331, 74, JMJD7 IN COMPLEX WITH MN AND 2OG IN THE H32 FORM
288, p3u78A1, 0.5188, 3.64, 0.054, 333, 74, E67-2 SELECTIVELY INHIBITS KIAA1718 A HUMAN HISTONE H3 LYSINE 9 JUMONJI DEMETHYLASE
289, p4s3lA2, 0.5186, 3.66, 0.054, 331, 74, CRYSTAL STRUCTURE OF MAJOR PILIN PROTEIN PITB FROM TYPE II PILUS OF STREPTOCOCCUS PNEUMONIAE
290, p3k3oA1, 0.5185, 3.65, 0.054, 333, 74, CRYSTAL STRUCTURE OF THE CATALYTIC CORE DOMAIN OF HUMAN PHF8 COMPLEXED WITH ALPHA-KETOGLUTARATE
291, p6egvA_, 0.5178, 3.47, 0.082, 300, 73, SACBROOD VIRUS OF HONEYBEE 
292, p5nfoB_, 0.5178, 3.76, 0.054, 308, 74, HUMAN JMJD7 IN COMPLEX WITH MN AND 2OG IN THE P21212 FORM
293, p4qm9B_, 0.5174, 3.93, 0.077, 197, 78, CRYSTAL STRUCTURE OF A PUTATIVE CYSTEINE DIOXYGNASE FROM BACILLUS SUBTILIS WITH CYS-BOUND
294, p4qm9A_, 0.5173, 3.40, 0.056, 178, 72, CRYSTAL STRUCTURE OF A PUTATIVE CYSTEINE DIOXYGNASE FROM BACILLUS SUBTILIS WITH CYS-BOUND
295, p4qu2A_, 0.5172, 3.68, 0.054, 332, 74, THE STRUCTURE OF JMJD7 WITH ALPHA-KG
296, p3uyjB_, 0.5168, 3.68, 0.054, 308, 74, CRYSTAL STRUCTURE OF JMJD5 CATALYTIC CORE DOMAIN IN COMPLEX WITH NICKLE AND ALPHA-KG
297, p4qknA1, 0.5167, 3.97, 0.077, 197, 78, CRYSTAL STRUCTURE OF FTO BOUND TO A SELECTIVE INHIBITOR
298, d1mzfA_, 0.5167, 3.61, 0.042, 276, 71, HUMAN FACTOR INHIBITING HIF (FIH1) IN COMPLEX WITH 2-OXOGLUTARATE
299, p3purA2, 0.5161, 3.61, 0.042, 276, 71, CEKDM7A FROM C.ELEGANS COMPLEX WITH D-2-HG
300, p3kvaA1, 0.5161, 3.92, 0.077, 206, 78, STRUCTURE OF KIAA1718 JUMONJI DOMAIN IN COMPLEX WITH ALPHA- KETOGLUTARATE
301, p4qszA3, 0.5156, 3.93, 0.077, 206, 78, CRYSTAL STRUCTURE OF MOUSE JMJD7 FUSED WITH MALTOSE-BINDING PROTEIN
302, p5l9wA2, 0.5151, 3.71, 0.054, 332, 74, CRYSTAL STRUCTURE OF THE APC CORE COMPLEX
303, p5a9bA_, 0.5147, 3.93, 0.077, 197, 78, CRYSTAL STRUCTURE OF BOMBYX MORI CPV1 POLYHEDRA BASE DOMAIN DELETED MUTANT
304, p4cxxA1, 0.5144, 3.92, 0.077, 197, 78, CRYSTAL STRUCTURE OF HUMAN FTO IN COMPLEX WITH ACYLHYDRAZINE INHIBITOR 16
305, p4s3lB2, 0.5143, 3.92, 0.077, 196, 78, CRYSTAL STRUCTURE OF MAJOR PILIN PROTEIN PITB FROM TYPE II PILUS OF STREPTOCOCCUS PNEUMONIAE
306, p5fy4A1, 0.5139, 3.23, 0.058, 218, 69, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JARID1B IN COMPLEX WITH SUCCINATE
307, d4xfaA_, 0.5138, 3.23, 0.058, 218, 69, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 8.0 IN COMPLEX WITH HOMOCYSTEINE
308, d4xf1A_, 0.5138, 3.70, 0.054, 308, 74, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 8.0 WITH CYSTEINE
309, p3puaA1, 0.5138, 3.70, 0.054, 292, 74, PHF2 JUMONJI-NOG-NI(II)
310, p3pusA1, 0.5136, 3.75, 0.082, 318, 73, PHF2 JUMONJI-NOG-NI(II)
311, p3n9mC2, 0.5136, 3.32, 0.042, 132, 72, CEKDM7A FROM C.ELEGANS ALONE
312, d1umhA1, 0.5131, 3.32, 0.042, 132, 72, STRUCTURAL BASIS OF SUGAR-RECOGNIZING UBIQUITIN LIGASE
313, p3wvzB1, 0.5129, 3.64, 0.065, 196, 77, CRYSTAL STRUCTURE OF HIKESHI A NEW NUCLEAR TRANSPORT RECEPTOR OF HSP70
314, p3pu8B1, 0.5129, 3.43, 0.029, 169, 68, PHF2 JUMONJI-NOG-FE(II) COMPLEX
315, p3ptrB1, 0.5129, 3.43, 0.029, 169, 68, PHF2 JUMONJI DOMAIN
316, d4xfiA_, 0.5126, 3.47, 0.054, 112, 74, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 6.2 WITH HOMOCYSTEINE
317, p4cugA1, 0.5125, 3.73, 0.029, 342, 70, RHODOTHERMUS MARINUS YCFD-LIKE RIBOSOMAL PROTEIN L16 ARGINYL HYDROXYLASE IN COMPLEX SUBSTRATE FRAGMENT
318, d4xf3A_, 0.5124, 3.56, 0.056, 308, 72, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 8.0 WITH CYSTEINE AND DITHIONITE
319, d4iezA_, 0.5124, 3.44, 0.054, 117, 74, UNLIGANDED CYSTEINE DIOXYGENASE AT PH 8.0
320, p3pu3A1, 0.5124, 3.61, 0.070, 233, 71, PHF2 JUMONJI DOMAIN-NOG COMPLEX
321, d4xezA_, 0.5120, 3.78, 0.054, 321, 74, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 8.0 WITH DITHIONITE
322, d4xetA_, 0.5120, 3.60, 0.070, 235, 71, FE-CL BOUND Y157F CDO AT PH ~7.0 IN THE PRESENCE OF AZIDE
323, p4cugB1, 0.5118, 3.77, 0.014, 332, 70, RHODOTHERMUS MARINUS YCFD-LIKE RIBOSOMAL PROTEIN L16 ARGINYL HYDROXYLASE IN COMPLEX SUBSTRATE FRAGMENT
324, d4ubgA_, 0.5116, 3.79, 0.054, 318, 74, RESTING STATE OF RAT CYSTEINE DIOXYGENASE C93G VARIANT
325, d5i0sA_, 0.5114, 3.76, 0.082, 318, 73, THIOSULFATE BOUND CYSTEINE DIOXYGENASE AT PH 6.2
326, d4xffA_, 0.5114, 3.82, 0.080, 286, 75, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 6.2 WITH DITHIONITE
327, d4ierA_, 0.5114, 3.39, 0.086, 162, 70, CYS-PERSULFENATE BOUND CYSTEINE DIOXYGENASE AT PH 5.5 IN THE PRESENCE OF CYS
328, d4xfhA_, 0.5113, 3.39, 0.086, 162, 70, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 6.2 WITH CYSTEINE
329, d5i0tA_, 0.5112, 3.84, 0.080, 243, 75, THIOSULFATE BOUND CYSTEINE DIOXYGENASE AT PH 6.8
330, d4yyoA_, 0.5112, 3.41, 0.074, 207, 68, RESTING STATE OF RAT CYSTEINE DIOXYGENASE C164S VARIANT
331, d4xfcA_, 0.5112, 3.58, 0.083, 318, 72, CYSTEINE DIOXYGENASE VARIANT - Y157F AT PH 6.2 UNLIGANDED
332, d5i0rA_, 0.5111, 3.40, 0.043, 152, 69, D-CYSTEINE BOUND C93A MUTANT OF CYSTEINE DIOXYGENASE AT PH 8
333, p3n9mA2, 0.5111, 3.42, 0.043, 154, 69, CEKDM7A FROM C.ELEGANS ALONE
334, d5efuA_, 0.5110, 3.42, 0.043, 154, 69, RESTING STATE OF RAT CYSTEINE DIOXYGENASE H155Q VARIANT
335, d4c8dA_, 0.5110, 3.59, 0.083, 318, 72, CRYSTAL STRUCTURE OF JMJC DOMAIN OF HUMAN HISTONE 3 LYSINE- SPECIFIC DEMETHYLASE 3B (KDM3B)
336, p3al6A1, 0.5109, 3.59, 0.083, 318, 72, CRYSTAL STRUCTURE OF HUMAN TYW5
337, p2yu1A1, 0.5109, 3.83, 0.056, 230, 72, CRYSTAL STRUCTURE OF HJHDM1A COMPLEXED WITH A-KETOGLUTARATE
338, d3s0mA_, 0.5108, 3.95, 0.083, 264, 72, A STRUCTURAL ELEMENT THAT MODULATES PROTON-COUPLED ELECTRON TRANSFER IN OXALATE DECARBOXYLASE
339, d4jtnA_, 0.5107, 3.88, 0.014, 335, 71, CYSTEINE DIOXYGENASE AT PH 8.0 IN THE PRESENCE OF DITHIONITE
340, d4xfbA_, 0.5106, 3.86, 0.054, 318, 74, CYSTEINE DIOXYGENASE VARIANT - C93A AT PH 8.0 UNLIGANDED
341, p5nfnA2, 0.5105, 3.84, 0.080, 286, 75, JMJD7 IN COMPLEX WITH MN AND 2OG IN THE H32 FORM
342, d4ietA_, 0.5105, 3.83, 0.125, 307, 72, CYS-PERSULFENATE BOUND CYSTEINE DIOXYGENASE AT PH 6.8 IN THE PRESENCE OF CYS
343, d2w0xA_, 0.5104, 3.92, 0.027, 201, 75, FACTOR INHIBITING HIF-1 ALPHA WITH PYRIDINE 24 DICARBOXYLIC ACID
344, d4yniA_, 0.5103, 3.92, 0.027, 201, 75, IRON FREE SUCCINATE BOUND RAT CYSTEINE DIOXYGENASE
345, d4ubhA_, 0.5103, 3.40, 0.055, 197, 73, RESTING STATE OF RAT CYSTEINE DIOXYGENASE Y157F VARIANT
346, d5ezwA_, 0.5102, 3.97, 0.083, 267, 72, THIOSULFATE BOUND RAT CYSTEINE DIOXYGENASE Y157H VARIANT
347, d4pixA_, 0.5102, 3.46, 0.085, 162, 71, UNLIGANDED CYSTEINE DIOXYGENASE C93A VARIANT AT PH 6.2
348, d2b5hA_, 0.5100, 3.58, 0.069, 308, 72, 1.5 A RESOLUTION CRYSTAL STRUCTURE OF RECOMBINANT R. NORVEGICUS CYSTEINE DIOXYGENASE
349, p6f4mA1, 0.5099, 3.48, 0.059, 186, 68, HUMAN JMJD5 IN ITS APO FORM.
350, d4piyA_, 0.5099, 3.46, 0.074, 186, 68, HOMOCYSTEINE BOUND CYSTEINE DIOXYGENASE C93A VARIANT AT PH 6.2
351, d4kwkA_, 0.5099, 3.93, 0.080, 290, 75, RAT CYSTEINE DIOXYGENASE WITH CYSTEINE PERSULFIDE BOUND TO ACTIVE SITE IRON
352, d4iepA_, 0.5099, 3.89, 0.080, 290, 75, UNLIGANDED CYSTEINE DIOXYGENASE AT PH 4.5 IN THE PRESENCE OF CYS
353, p4gjzA_, 0.5099, 3.93, 0.054, 316, 74, JMJD5 IN COMPLEX WITH 2-OXOGLUTARATE
354, d4kwjA_, 0.5097, 3.14, 0.099, 181, 71, RESTING STATE OF RAT CYSTEINE DIOXYGENASE
355, d4tlfA_, 0.5096, 3.14, 0.099, 181, 71, CRYSTAL STRUCTURE OF THIOL DIOXYGENASE FROM PSEUDOMONAS AERUGINOSA
356, d4iexA_, 0.5096, 3.38, 0.056, 119, 72, UNLIGANDED ROOM-TEMP CYSTEINE DIOXYGENASE AT PH 6.2
357, d4fqzA1, 0.5096, 3.89, 0.080, 290, 75, CRYSTAL STRUCTURE OF A PROTEASE-RESISTANT MUTANT FORM OF HUMAN GALECTIN-8
358, d5fdbA_, 0.5095, 3.90, 0.080, 290, 75, IRON FREE RAT CYSTEINE DIOXYGENASE R60QC164R VARIANT
359, d4xfgA_, 0.5095, 3.47, 0.074, 186, 68, CYSTEINE DIOXYGENASE VARIANT - C93A AT PH 6.2 WITH CYSTEINE
360, d5vg3C_, 0.5094, 3.70, 0.056, 212, 71, STRUCTURE OF OXALATE DECARBOXYLASE FROM BACILLUS SUBTILIS AT PH 4.6
361, d4tlfD_, 0.5094, 3.48, 0.074, 186, 68, CRYSTAL STRUCTURE OF THIOL DIOXYGENASE FROM PSEUDOMONAS AERUGINOSA
362, p3lfmA1, 0.5094, 3.46, 0.074, 186, 68, CRYSTAL STRUCTURE OF THE FAT MASS AND OBESITY ASSOCIATED (FTO) PROTEIN REVEALS BASIS FOR ITS SUBSTRATE SPECIFICITY
363, d3ussA_, 0.5093, 3.91, 0.080, 290, 75, CRYSTAL STRUCTURE OF CYSTEINE DIOXYGENASE FROM PSEUDOMONAS AERUGINOSA
364, d4pizA_, 0.5091, 3.46, 0.074, 186, 68, HOMOCYSTEINE-BOUND CYSTEINE DIOXYGENASE AT PH 6.2
365, d3najA1, 0.5090, 3.47, 0.074, 187, 68,  
366, d4iewA_, 0.5089, 3.67, 0.071, 212, 70, CYS-ONLY BOUND CYSTEINE DIOXYGENASE AT PH 9.0 IN THE PRESENCE OF CYS
367, p5nfnC2, 0.5088, 3.52, 0.072, 187, 69, JMJD7 IN COMPLEX WITH MN AND 2OG IN THE H32 FORM
368, d4xf0A_, 0.5088, 3.46, 0.074, 185, 68, CYSTEINE DIOXYGENASE VARIANT - C93A AT PH 8.0 WITH CYSTEINE
369, d1uijD1, 0.5087, 3.46, 0.074, 186, 68, CRYSTAL STRUCTURE OF SOYBEAN BETA-CONGLYCININ BETA HOMOTRIMER (I122M/K124W)
370, d4wvzD1, 0.5085, 3.47, 0.074, 186, 68, CRYSTAL STRUCTURE OF ARTIFICIAL CROSSLINKED THIOL DIOXYGENASE G95C VARIANT FROM PSEUDOMONAS AERUGINOSA
371, p2vzpA_, 0.5085, 3.47, 0.074, 186, 68, ATOMIC RESOLUTION STRUCTURE OF THE C-TERMINAL CBM35 FROM AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA
372, d4ieyA_, 0.5084, 3.47, 0.074, 185, 68, CYS-PERSULFENATE BOUND CYSTEINE DIOXYGENASE AT PH 7.0 IN THE PRESENCE OF CYS HOME-SOURCE STRUCTURE
373, d4ieqA_, 0.5084, 3.48, 0.074, 187, 68, UNLIGANDED CYSTEINE DIOXYGENASE AT PH 5.0 IN THE PRESENCE OF CYS
374, d1iz3A_, 0.5084, 3.47, 0.074, 186, 68, DIMERIC STRUCTURE OF FIH (FACTOR INHIBITING HIF)
375, d5i0uA_, 0.5082, 3.48, 0.074, 186, 68, INCOMPLETELY INTERPRETED D-CYSTEINE SOAK OF CYSTEINE DIOXYGENASE AT PH 7.0
376, d4wvzC1, 0.5082, 3.98, 0.040, 306, 75, CRYSTAL STRUCTURE OF ARTIFICIAL CROSSLINKED THIOL DIOXYGENASE G95C VARIANT FROM PSEUDOMONAS AERUGINOSA
377, d2gh2A_, 0.5082, 3.46, 0.059, 187, 68, 1.5 A RESOLUTION R. NORVEGICUS CYSTEINE DIOXYGENASE STRUCTURE CRYSTALLIZED IN THE PRESENCE OF CYSTEINE
378, p4igpA_, 0.5081, 3.51, 0.072, 332, 69, HISTONE H3 LYSINE 4 DEMETHYLATING RICE JMJ703 APO ENZYME
379, d4iesA_, 0.5081, 3.17, 0.076, 149, 66, CYS-PERSULFENATE BOUND CYSTEINE DIOXYGENASE AT PH 6.2 IN THE PRESENCE OF CYS
380, d4wvzA_, 0.5080, 3.86, 0.040, 251, 75, CRYSTAL STRUCTURE OF ARTIFICIAL CROSSLINKED THIOL DIOXYGENASE G95C VARIANT FROM PSEUDOMONAS AERUGINOSA
381, d4pjyA_, 0.5080, 3.18, 0.061, 377, 66, AZIDE BOUND CYSTEINE DIOXYGENASE AT PH 6.2
382, d4ievA_, 0.5078, 3.47, 0.074, 186, 68, CYS-ONLY BOUND CYSTEINE DIOXYGENASE AT PH 8.0 IN THE PRESENCE OF CYS
383, d4ieuA_, 0.5077, 3.48, 0.074, 186, 68, CYS-PERSULFENATE BOUND CYSTEINE DIOXYGENASE AT PH 7.0 IN THE PRESENCE OF CYS
384, d4jtoA_, 0.5076, 3.32, 0.088, 159, 68, CYSTEINE BOUND CYSTEINE DIOXYGENASE AT PH 8.0 IN THE PRESENCE OF CYS AND DITHIONITE
385, p3al6D_, 0.5075, 3.47, 0.074, 186, 68, CRYSTAL STRUCTURE OF HUMAN TYW5
386, d4xf4A_, 0.5073, 3.78, 0.014, 342, 71, CYSTEINE DIOXYGENASE AT PH 8.0 IN COMPLEX WITH HOMOCYSTEINE
387, d4wvzB_, 0.5073, 3.48, 0.074, 187, 68, CRYSTAL STRUCTURE OF ARTIFICIAL CROSSLINKED THIOL DIOXYGENASE G95C VARIANT FROM PSEUDOMONAS AERUGINOSA
388, d4z82A_, 0.5071, 3.47, 0.059, 187, 68, CYSTEINE BOUND RAT CYSTEINE DIOXYGENASE C164S VARIANT AT PH 8.1
389, p6f4sA_, 0.5070, 3.48, 0.074, 187, 68, HUMAN JMJD5 (N308C) IN COMPLEX WITH MN(II) 2OG AND RCCD1 (139-143) (COMPLEX-4)
390, d2vecA_, 0.5070, 3.48, 0.074, 186, 68, THE CRYSTAL STRUCTURE OF THE PROTEIN YHAK FROM ESCHERICHIA COLI
391, d4xf9A_, 0.5068, 3.49, 0.074, 186, 68, CYSTEINE DIOXYGENASE VARIANT - C93A AT PH 8.0 IN COMPLEX WITH HOMOCYSTEINE
392, d1uijA1, 0.5064, 3.32, 0.074, 172, 68, CRYSTAL STRUCTURE OF SOYBEAN BETA-CONGLYCININ BETA HOMOTRIMER (I122M/K124W)
393, p4cswB1, 0.5063, 3.49, 0.074, 186, 68, RHODOTHERMUS MARINUS YCFD-LIKE RIBOSOMAL PROTEIN L16 ARGINYL HYDROXYLASE
394, d4ysfA_, 0.5062, 3.48, 0.074, 187, 68, RESTING STATE OF RAT CYSTEINE DIOXYGENASE H155N VARIANT
395, d3ussB_, 0.5062, 3.49, 0.074, 186, 68, CRYSTAL STRUCTURE OF CYSTEINE DIOXYGENASE FROM PSEUDOMONAS AERUGINOSA
396, d3elnA_, 0.5060, 3.66, 0.083, 228, 72, A PUTATIVE FE2+-BOUND PERSULFENATE INTERMEDIATE IN CYSTEINE DIOXYGENASE
397, d4kwlA_, 0.5059, 3.48, 0.074, 187, 68, RAT CYSTEINE DIOXYGENASE WITH 3-MERCAPTOPROPIONIC ACID PERSULFIDE BOUND
398, d4tlfB_, 0.5058, 3.33, 0.044, 194, 68, CRYSTAL STRUCTURE OF THIOL DIOXYGENASE FROM PSEUDOMONAS AERUGINOSA
399, d4ieoA_, 0.5058, 3.47, 0.074, 186, 68, UNLIGANDED CYSTEINE DIOXYGENASE AT PH 4.0 IN THE PRESENCE OF CYS
400, d3vkmB1, 0.5055, 3.38, 0.042, 154, 71, PROTEASE-RESISTANT MUTANT FORM OF HUMAN GALECTIN-8 IN COMPLEX WITH SIALYLLACTOSE AND LACTOSE
401, d4tlfC_, 0.5054, 3.53, 0.058, 187, 69, CRYSTAL STRUCTURE OF THIOL DIOXYGENASE FROM PSEUDOMONAS AERUGINOSA
402, p4qm8A_, 0.5051, 3.48, 0.074, 186, 68, CRYSTAL STRUCTURE OF A PUTATIVE CYSTEINE DIOXYGNASE FROM BACILLUS SUBTILIS: A ALTERNATIVE MODELING OF 3EQE
403, d6bgmA_, 0.5045, 3.19, 0.061, 377, 66, CRYSTAL STRUCTURE OF FERROUS FORM OF THE CROSSLINKED HUMAN CYSTEINE DIOXYGENASE
404, p4qm8B_, 0.5045, 3.43, 0.074, 198, 68, CRYSTAL STRUCTURE OF A PUTATIVE CYSTEINE DIOXYGNASE FROM BACILLUS SUBTILIS: A ALTERNATIVE MODELING OF 3EQE
405, p6bptA_, 0.5041, 4.00, 0.070, 258, 71, CRYSTAL STRUCTURE OF FERROUS FORM OF THE UNCROSSLINKED F2-TYR157 HUMAN CYSTEINE DIOXYGENASE 
406, p5xoiA_, 0.5041, 3.35, 0.044, 196, 68, THE STRUCTURE OF OSALKBH1 
407, p4cswA1, 0.5039, 3.49, 0.074, 186, 68, RHODOTHERMUS MARINUS YCFD-LIKE RIBOSOMAL PROTEIN L16 ARGINYL HYDROXYLASE
408, d6bgfA_, 0.5037, 3.37, 0.042, 154, 71, CRYSTAL STRUCTURE OF CYSTEINE-BOUND FERROUS FORM OF THE CROSSLINKED HUMAN CYSTEINE DIOXYGENASE
409, p2rg4B_, 0.5037, 3.37, 0.042, 154, 71, CRYSTAL STRUCTURE OF THE UNCHARACTERIZED PROTEIN Q2CBJ1_9RHOB FROM OCEANICOLA GRANULOSUS HTCC2516
410, p2ea7C2, 0.5036, 3.48, 0.059, 186, 68, CRYSTAL STRUCTURE OF ADZUKI BEAN 7S GLOBULIN-1
411, d5vg3A_, 0.5035, 3.73, 0.083, 190, 72, STRUCTURE OF OXALATE DECARBOXYLASE FROM BACILLUS SUBTILIS AT PH 4.6
412, d3o1uA_, 0.5034, 3.73, 0.083, 190, 72, IRON-CATALYZED OXIDATION INTERMEDIATES CAPTURED IN A DNA REPAIR DIOXYGENASE
413, p2ea7B2, 0.5034, 3.49, 0.059, 186, 68, CRYSTAL STRUCTURE OF ADZUKI BEAN 7S GLOBULIN-1
414, p5m21F2, 0.5033, 3.50, 0.000, 170, 66, CRYSTAL STRUCTURE OF HYDROQUINONE 12-DIOXYGENASE FROM SPHINGOMONAS SP. TTNP3 WITH 4-HYDROXYBENZOATE BOUND
415, p4gazB_, 0.5033, 3.40, 0.059, 199, 68, CRYSTAL STRUCTURE OF A JUMONJI DOMAIN-CONTAINING PROTEIN JMJD5
416, p2ea7A2, 0.5033, 3.40, 0.059, 199, 68, CRYSTAL STRUCTURE OF ADZUKI BEAN 7S GLOBULIN-1
417, d2atfA1, 0.5033, 3.69, 0.070, 126, 71, X-RAY STRUCTURE OF CYSTEINE DIOXYGENASE TYPE I FROM MUS MUSCULUS MM.241056
418, d1ipkC1, 0.5032, 3.49, 0.059, 186, 68, CRYSTAL STRUCTURES OF RECOMBINANT AND NATIVE SOYBEAN BETA- CONGLYCININ BETA HOMOTRIMERS
419, p6bpsA_, 0.5029, 3.37, 0.075, 186, 67, CRYSTAL STRUCTURE OF CYSTEINE-BOUND FERROUS FORM OF THE UNCROSSLINKED F2-TYR157 HUMAN CYSTEINE DIOXYGENASE 
420, d2ic1A1, 0.5029, 3.62, 0.014, 330, 69, CRYSTAL STRUCTURE OF HUMAN CYSTEINE DIOXYGENASE IN COMPLEX WITH SUBSTRATE CYSTEINE
421, d1caxE_, 0.5028, 3.49, 0.059, 185, 68, DETERMINATION OF THREE CRYSTAL STRUCTURES OF CANAVALIN BY MOLECULAR REPLACEMENT
422, p4ccoA1, 0.5027, 3.38, 0.044, 198, 68, 60S RIBOSOMAL PROTEIN L8 HISTIDINE HYDROXYLASE (NO66 S373C) IN COMPLEX WITH MN(II) N-OXALYLGLYCINE (NOG) AND 60S RIBOSOMAL PROTEIN L8 (RPL8 G214C) PEPTIDE FRAGMENT (COMPLEX-3)
423, p5m26D2, 0.5026, 3.51, 0.074, 186, 68, CRYSTAL STRUCTURE OF HYDROQUINONE 12-DIOXYGENASE FROM SPHINGOMONAS SP. TTNP3 IN COMPLEX WITH METHYLHYDROQUINONE
424, p2w46A_, 0.5025, 3.37, 0.028, 270, 72, CBM35 FROM CELLVIBRIO JAPONICUS ABF62
425, p5m4oD2, 0.5023, 3.50, 0.059, 186, 68, CRYSTAL STRUCTURE OF HYDROQUINONE 12-DIOXYGENASE FROM SPHINGOMONAS SP. TTNP3 IN COMPLEX WITH 4-NITROPHENOL
426, p6cdnA_, 0.5022, 3.34, 0.044, 195, 68, CRYSTAL STRUCTURE OF CYSTEINE-BOUND FERROUS FORM OF THE CROSSLINKED CL-TYR157 HUMAN CYSTEINE DIOXYGENASE 
427, d1caxC_, 0.5022, 3.50, 0.074, 186, 68, DETERMINATION OF THREE CRYSTAL STRUCTURES OF CANAVALIN BY MOLECULAR REPLACEMENT
428, p5m22B2, 0.5017, 3.50, 0.059, 186, 68, CRYSTAL STRUCTURE OF HYDROQUINONE 12-DIOXYGENASE FROM SPHINGOMONAS SP. TTNP3
429, p4cckB1, 0.5016, 3.50, 0.059, 186, 68, 60S RIBOSOMAL PROTEIN L8 HISTIDINE HYDROXYLASE (NO66) IN COMPLEX WITH MN(II) AND N-OXALYLGLYCINE (NOG)
430, d3vkmA1, 0.5015, 3.49, 0.059, 186, 68, PROTEASE-RESISTANT MUTANT FORM OF HUMAN GALECTIN-8 IN COMPLEX WITH SIALYLLACTOSE AND LACTOSE
431, d3kcxA_, 0.5014, 3.53, 0.100, 273, 70, FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CLIOQUINOL
432, d1dgrC_, 0.5014, 3.50, 0.059, 186, 68, REFINED CRYSTAL STRUCTURE OF CANAVALIN FROM JACK BEAN
433, p6cb4A2, 0.5013, 3.35, 0.044, 195, 68, HIGH RESOLUTION STRUCTURE OF THE HEXAGONAL CRYSTAL FORM OF THE VICILIN PROTEIN CANAVALIN IN COMPLEX WITH ENDOGENOUS BENZOIC ACID
434, d1uijE1, 0.5013, 3.51, 0.059, 186, 68, CRYSTAL STRUCTURE OF SOYBEAN BETA-CONGLYCININ BETA HOMOTRIMER (I122M/K124W)
435, p4do0A1, 0.5012, 3.70, 0.083, 235, 72, CRYSTAL STRUCTURE OF HUMAN PHF8 IN COMPLEX WITH DAMINOZIDE
436, p6bpwA_, 0.5011, 3.37, 0.030, 226, 66, CRYSTAL STRUCTURE OF FERROUS FORM OF THE CL2-TYR157 HUMAN CYSTEINE DIOXYGENASE WITH BOTH UNCROSSLINKED AND CROSSLINKED COFACTOR 
437, d1uijF1, 0.5011, 3.37, 0.030, 226, 66, CRYSTAL STRUCTURE OF SOYBEAN BETA-CONGLYCININ BETA HOMOTRIMER (I122M/K124W)
438, p5xegA_, 0.5010, 3.51, 0.059, 186, 68, THE STRUCTURE OF OSALKBH1 
439, p2eaaA2, 0.5010, 3.38, 0.000, 170, 65, CRYSTAL STRUCTURE OF ADZUKI BEAN 7S GLOBULIN-3
440, p2w87B_, 0.5009, 3.80, 0.069, 212, 72, XYL-CBM35 IN COMPLEX WITH GLUCURONIC ACID CONTAINING DISACCHARIDE.
441, d1h2nA_, 0.5008, 3.55, 0.058, 187, 69, FACTOR INHIBITING HIF-1 ALPHA
442, p6cdhA_, 0.5006, 3.43, 0.043, 196, 69, CRYSTAL STRUCTURE OF FERROUS FORM OF THE CL-TYR157 HUMAN CYSTEINE DIOXYGENASE WITH BOTH UNCROSSLINKED AND CROSSLINKED COFACTOR 
443, d3o1tA_, 0.5006, 3.51, 0.059, 187, 68, IRON-CATALYZED OXIDATION INTERMEDIATES CAPTURED IN A DNA REPAIR DIOXYGENASE
444, p3j31Q2, 0.5005, 3.51, 0.059, 187, 68, LIFE IN THE EXTREMES: ATOMIC STRUCTURE OF SULFOLOBUS TURRETED ICOSAHEDRAL VIRUS
445, p4y4rB1, 0.5004, 3.37, 0.044, 193, 68, CRYSTAL STRUCTURE OF RIBOSOMAL OXYGENASE NO66 DIMER MUTANT
446, d2wa4A_, 0.5004, 3.54, 0.059, 186, 68, FACTOR INHIBITING HIF-1 ALPHA WITH N3-DIHYDROXYBENZAMIDE
447, d1pm7A_, 0.5004, 3.40, 0.042, 154, 72, RMLC (DTDP-6-DEOXY-D-XYLO-4-HEXULOSE 35-EPIMERASE)STRUCTURE FROM MYCOBACTERIUM TUBERCULOSIS AND INHIBITOR DESIGN. THE APO STRUCTURE.
448, p2eaaB2, 0.5003, 3.38, 0.044, 196, 68, CRYSTAL STRUCTURE OF ADZUKI BEAN 7S GLOBULIN-3
449, d2cavA1, 0.5003, 3.39, 0.015, 149, 67, CANAVALIN FROM JACK BEAN
450, p4ccjC1, 0.5002, 3.54, 0.044, 187, 68, 60S RIBOSOMAL PROTEIN L8 HISTIDINE HYDROXYLASE (NO66) IN APO FORM
451, d1pm7B_, 0.5002, 3.41, 0.015, 147, 67, RMLC (DTDP-6-DEOXY-D-XYLO-4-HEXULOSE 35-EPIMERASE)STRUCTURE FROM MYCOBACTERIUM TUBERCULOSIS AND INHIBITOR DESIGN. THE APO STRUCTURE.
452, d1h2kA_, 0.5002, 3.54, 0.044, 185, 68, FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH HIF-1 ALPHA FRAGMENT PEPTIDE
453, d3kcyA_, 0.5001, 4.14, 0.065, 227, 77, FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH 8-HYDROXYQUINOLINE
